COVID-19 vaccine doses administered per 100 people

This is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dos...

February 9, 2021 | Tuesday | News
SmartBreast buys molecular breast imaging assets from GE Healthcare

SmartBreast Corporation (SmartBreast™), a privately held company with headquarters near Pittsburgh, US&n...

February 8, 2021 | Monday | News
GlobalData reports the status of Global COVID-19 vaccine trials

While governments are ramping up vaccination programs, continued research into the effectiveness of the vaccines is impe...

February 8, 2021 | Monday | Analysis
USP expands alcohol-based hand sanitiser support

In response to the alcohol-based hand sanitiser quality incidents reported across the globe, the US Pharmacopeia (USP) i...

February 4, 2021 | Thursday | News
WHO issues new 10-year plan to end suffering from neglected tropical diseases

A new World Health Organization (WHO) road map for neglected tropical diseases (NTDs) proposes ambitious targets and inn...

February 2, 2021 | Tuesday | News
Novavax COVID-19 Vaccine demonstrates 89.3% efficacy in UK Phase 3 Trial

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced th...

February 2, 2021 | Tuesday | News
Bharat Biotech inks agreement with GSK, PATH to supply world's first malaria vaccine

GSK, PATH, and Bharat Biotech (BBIL) on Jan 27, 2021, announced the signing of a product transfer agreement for the mala...

January 31, 2021 | Sunday | News
Merck bolsters Rwanda’s plan to eliminate schistosomiasis by 2024

Merck, a leading science and technology company, and the END Fund have announced their partnership to provide Rwanda wit...

February 1, 2021 | Monday | News
CEPI Call provides up to $140 M in funding to vaccine developers

Norway based CEPI, the Coalition for Epidemic Preparedness Innovations, has opened a new funding opportunity to support ...

January 29, 2021 | Friday | News
Eppendorf & Science call out entries for Neurobiology Prize 2021

Eppendorf and the journal Science are now accepting applications for the 2021 Eppendorf & Science Prize for Neurobio...

January 27, 2021 | Wednesday | News
COVAX announces new agreement, plans for initial doses of vaccine deliveries

COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardle...

January 25, 2021 | Monday | News
Thermo Fisher Scientific to acquire Mesa Biotech for $450M

Thermo Fisher Scientific Inc., the world leader in serving science, on Jan 19, 2021 announced it has entered into a...

January 21, 2021 | Thursday | News
Pfizer and BioNTech invitro vaccine study shows efficient neutralization of SARS-CoV-2 U.K. strain

Pfizer Inc and BioNTech SE on Jan 20, 2021 announced results from an in vitro study that provides additional d...

January 21, 2021 | Thursday | News
Novartis, GSK explore African genetic diversity for malaria, TB treatment

Novartis and GSK has announced the launch of a collaboration to support high-quality scientific research investigating t...

January 20, 2021 | Wednesday | News
Scientists address vaccine safety & efficacy at global R&D forum

More than 2,800 scientists from 130 countries gathered in a virtual forum last week hosted by the World Health Organizat...

January 19, 2021 | Tuesday | News
WHO's Emergency Committee to review the emerging variants of SARS-CoV-2

The sixth meeting of the Emergency Committee (EC) convened by the WHO Director-General under the International Heal...

January 18, 2021 | Monday | News
Thermo Fisher Scientific acquires viral vector manufacturing business

Thermo Fisher Scientific Inc. and Groupe Novasep SAS, a leading supplier of services and technologies for the life scien...

January 18, 2021 | Monday | News
PerkinElmer SARS-CoV-2 RT-PCR assay receives FDA EUA for asymptomatic testing

PerkinElmer, Inc. announced on Jan 14, 2021 that its PerkinElmer® New Coronavirus Nucleic Acid D...

January 15, 2021 | Friday | News